User profiles for Priyanka Mehta

Priyanka Mehta

CSIR-Institue of Genomics and Integrative Biology
Verified email at igib.in
Cited by 634

Genomic characterization and epidemiology of an emerging SARS-CoV-2 variant in Delhi, India

…, M Imran, V Senthivel, R Maurya, N Jha, P Mehta… - Science, 2021 - science.org
Delhi, the national capital of India, experienced multiple severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) outbreaks in 2020 and reached population seropositivity of >50…

Quizartinib versus salvage chemotherapy in relapsed or refractory FLT3-ITD acute myeloid leukaemia (QuANTUM-R): a multicentre, randomised, controlled, open …

…, D Hogge, BA Jonas, AYH Leung, P Mehta… - The Lancet …, 2019 - thelancet.com
Background Patients with relapsed or refractory FLT3 internal tandem duplication (FLT3-ITD)-positive
acute myeloid leukaemia have a poor prognosis, including high frequency of …

[HTML][HTML] Iron deficiency anemia: efficacy and limitations of nutritional and comprehensive mitigation strategies

SB Kumar, SR Arnipalli, P Mehta, S Carrau… - Nutrients, 2022 - mdpi.com
Iron deficiency anemia (IDA) has reached epidemic proportions in developing countries and
has become a major global public health problem, affecting mainly 0–5-year-old children …

[HTML][HTML] Severe SARS-CoV-2 breakthrough reinfection with delta variant after recovery from breakthrough infection by alpha variant in a fully vaccinated health worker

…, N Chatterjee, R Shah, P Devi, P Mehta… - Frontiers in …, 2021 - frontiersin.org
Background: Post infection immunity and post vaccination immunity both confer protection
against COVID-19. However, there have been many whole genome sequencing proven …

Molecular MRD status and outcome after transplantation in NPM1-mutated AML

…, S Knapper, H Kaur, D Taussig, P Mehta… - Blood, The Journal …, 2020 - ashpublications.org
Relapse remains the most common cause of treatment failure for patients with acute myeloid
leukemia (AML) who undergo allogeneic stem cell transplantation (alloSCT), and carries a …

Momelotinib versus danazol in symptomatic patients with anaemia and myelofibrosis (MOMENTUM): results from an international, double-blind, randomised …

…, J McCloskey, C McDermott, B McMahon, P Mehta… - The Lancet, 2023 - thelancet.com
Background Janus kinase (JAK) inhibitors approved for myelofibrosis provide spleen and
symptom improvements but do not meaningfully improve anaemia. Momelotinib, a first-in-class …

[HTML][HTML] The complex genetic landscape of familial MDS and AML reveals pathogenic germline variants

…, M Layton, AM Male, J Marsh, P Mehta… - Nature …, 2020 - nature.com
The inclusion of familial myeloid malignancies as a separate disease entity in the revised
WHO classification has renewed efforts to improve the recognition and management of this …

[HTML][HTML] Co-infections as modulators of disease outcome: minor players or major players?

P Devi, A Khan, P Chattopadhyay, P Mehta… - Frontiers in …, 2021 - frontiersin.org
Human host and pathogen interaction is dynamic in nature and often modulated by co-pathogens
with a functional role in delineating the physiological outcome of infection. Co-infection …

Converting a geriatrics clinic to virtual visits during COVID-19: a case study

S Iyer, P Mehta, J Weith, D Hoang-Gia… - Journal of primary …, 2021 - journals.sagepub.com
Background: To characterize the experience of converting a geriatrics clinic to telehealth visits
in early stages of a pandemic. Design: An organizational case study with mixed methods …

Increased abundance of Achromobacter xylosoxidans and Bacillus cereus in upper airway transcriptionally active microbiome of COVID-19 mortality patients indicates …

P Devi, R Maurya, P Mehta, U Shamim… - Microbiology …, 2022 - Am Soc Microbiol
The modulators of severe COVID-19 have emerged as the most intriguing features of SARS-CoV-2
pathogenesis. This is especially true as we are encountering variants of concern (…